EU Approves Gazyvaro (obinutuzumab) as a Treatment for Advanced Follicular Lymphoma
News
Roche announced that the European Commission has approved Gazyvaro (obinutuzumab), combined with bendamustine chemotherapy, to treat follicular lymphoma patients who have failed to respond to, or whose disease progressed despite, treatment with rituximab (MabThera) or a ... Read more